May 1, 2019
The U.S. Food and Drug Administration (FDA) will hold a public meeting on June 5, 2019, from 2:00 p.m. to 4:00 p.m., at the Harvey W. Wiley Federal Building, 5001 Campus Drive, Auditorium (first floor), College Park, MD 20740 to solicit input on topics that may be relevant for further discussion at the upcoming ICCR-13 Meeting. The closing date to register for attendance or to request to make an oral presentation is May 22, 2019.
Input gathered at this meeting will help the agency prepare for the International Cooperation on Cosmetics Regulation-13 (ICCR-13) meeting to be held July 9-11, 2019, in Montreal, Canada. ICCR is a voluntary international group of cosmetics regulatory authorities from Brazil, Canada, the European Union, Japan, and the United States. The ICCR members work together to make decisions through consensus that will be compatible with the laws, policies, rules, regulations and directives of the respective administrations and governments. The FDA encourages members of the public to present proposals for future ICCR agenda items and/or data, information, or views on pending issues orally or in writing at the public meeting. Members of the public may attend the meeting either in person or by phone, however there will be no presentations by phone. Registration information is available in the Federal Register Notice.
Important Dates to Remember:
- May 22, 2019: Request to make oral comments
- May 22, 2019: Advance registration
- May 29, 2019: Request special accommodations due to disability
- June 5, 2019: Public Meeting from 2:00 p.m. to 4:00 p.m.